Biological Variation in HbA1c Predicts Risk of Retinopathy and Nephropathy in Type 1 Diabetes
- 1 January 2005
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 28 (1) , 234-235
- https://doi.org/10.2337/diacare.28.1.234
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Biological Variation in HbA1c Predicts Risk of Retinopathy and Nephropathy in Type 1 DiabetesDiabetes Care, 2005
- Biological Variation in HbA1c Predicts Risk of Retinopathy and Nephropathy in Type 1 DiabetesDiabetes Care, 2004
- High and low hemoglobin glycation phenotypes in type 1 diabetesJournal of Diabetes and its Complications, 2002
- Defining the Relationship Between Plasma Glucose and HbA1cDiabetes Care, 2002
- The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications TrialDiabetologia, 2001
- Biological Variation of Glycated Hemoglobin: Implications for diabetes screening and monitoringDiabetes Care, 1998
- Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research GroupDiabetes Care, 1987